DOJ's CVS-Aetna Deal Set For Review, But Don't Call It A Trial
The U.S. Department of Justice deal clearing CVS' $69 billion purchase of Aetna will be subjected to three days of live witness testimony next month in a scaled-down version of what...To view the full article, register now.
Already a subscriber? Click here to view full article